accacuteadministrationadverseahaamericananalysisanticoagulantantiplateletaorticapixabanapplicationarterialarteryasianaspirinassociatedassociationatheroscleroticatrialbasedbenefitsbetableedingblockerblockersbloodbodybypasscalledcardiaccardiogeniccardiomyopathycardiovascularcarotidcenterchronicclinicalclopidogrelcohortcollegecombinationcombinedcommitteecomparedcomparingcomparisoncongresscontemporarycontrolledcoronarycriticallydaptdatadiabetesdiseasedualearlyedgeeffecteffectivenesseffectsefficacyejectionelevationendovascularesceventsexploringfactorsfailurefibrillationflowfollowingfractionfunctionglobalgraftingguidelineguidelineshbrhearthfhfpefhfrefhighhighlightshospitalhypertensionhypertrophicillimpactimplementationimprovesincidenceindexindividualinfarctioninhibitorinhibitorsinitiationinjuryinsightsinterventionischemicjointkeyleftlevellongmajormanagementmedicalmellitusmetametoprololmitralmoderatemonotherapymortalitymyocardialobstructiveoptimaloraloutcomesp2y12patientpatientspcipediatricpercutaneousperipheralplateletpluspointspostpreservedpressurepreventionprimaryprognosisprognosticpulmonaryrandomizedrapidraterealreducedreducingreductionregistryregurgitationremodelingrepairreperfusionreportresultsretrospectiverevascularizationreviewriskrivaroxabansafetysecondarysegmentseveresexshockshortsizeststemistentingstrokestudysyndromesyndromessystematicsystemictermtherapyticagrelortimingtranscathetertreatedtreatmenttreatmentstrialtrialstwilighttypeundergoingusevaluevalveventricularversuswithoutworldyoung